Vanberra Signal
Free trial

Cardea Bio

Curated by Signal

Developer of digital graphene biosensors using ML

Life Sciences Technologycardeabio.com

Overview

Cardea Bio is a developer of digital graphene biosensors using MLeveloper of digital graphene biosensors using ML. The company's proprietary product includes Biology-gated Transistors/ Cardean Transistors which is based on its patented Field Effect Biosensing (FEB) technology. This technology is used to build chipsets, such as CRISPR-Chip. The company's technology platform combines molecular biology, graphene, nano-physics, and advanced electronics, software, and ML/AI to produce a signal detection system.

Key facts

Founded
2019
Headquarters
San Diego, United States
Stage
Sign up to view
Industry
Life Sciences Technology

Contact

Primary office
Sign up to view
Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Cardiac Profiles

    Wearable cardiac monitoring device

    Life Sciences TechnologyNashville, United States

  • ExpressionEdits

    Provider of protein expression platform development services

    Life Sciences TechnologyCambridge, United States

  • BioVigil

    Provider of hand hygiene compliance system

    Life Sciences TechnologyDetroit, United States

About Cardea Bio

What does Cardea Bio do?

Cardea Bio is a developer of digital graphene biosensors using MLeveloper of digital graphene biosensors using ML.

Where is Cardea Bio headquartered?

Cardea Bio is headquartered in San Diego, United States.

When was Cardea Bio founded?

Cardea Bio was founded in 2019.

Which sector is Cardea Bio in?

Cardea Bio operates in Life Sciences Technology.

Who are Cardea Bio's competitors?

Companies similar to Cardea Bio include Cardiac Profiles, ExpressionEdits, and BioVigil.